U.S. Markets open in 1 hr, 55 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,450.95 | 132.79 | 1.29% |
| NASDAQ | 2,176.01 | 29.97 | 1.40% |
| S&P 500 | 1,106.24 | 14.86 | 1.36% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 11.71 02:47 PM EST | |
|---|---|---|
| Day High | 12.32 10:01 AM EST |
|
| Range | 0.61 |
| Volume | 148,728 | |
|---|---|---|
| 30-Day Avg Vol | 205,000 |
|
| Difference | -27.45% |
| Market Cap | 393.59 M | |
|---|---|---|
| Mkt Cap Chg | -3.64 M |
| Shares Out | 33.10 M | |
|---|---|---|
| % Shrs Traded | 0.45% | |
| 1yr EPS Est | -1.223 |
| 52-Wk Low | 6.86 | |
|---|---|---|
| 52-Wk High | 15.17 |
|
| Range | 8.31 |
| Prev Close | 12.00 11/20/09 | |
|---|---|---|
| Today's Open | 12.04 | |
| Change | 0.33% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 2.75 M |
| Revenue (LFY) | 1.02 M | |
|---|---|---|
| Earnings (LFY) | -35.58 M | |
| Earnings (MRQ) | -9.41 M | |
| Next Earn Est | -0.34 | |
| Next Earnings | 11/17/2009 |
|
| EPS (TTM) | -1.36 | |
| 1yr EPS Growth | 10.07% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -9.00 | |
| PEG Ratio | — | |
| Return on Equity | -81.37 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Optimer Pharmaceuticals has something for those "oh no, gotta go" moments. The company develops drug candidates for treating a variety of gastrointestinal infections. Its lead candidate, OPT-80, is in ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.34 N/A | — — |
—
—
|
| Last Quarter | -0.369 9/30/09 | -0.28 9/30/09 |
0.089
Beat
|
| 2 Quarters Ago | -0.332 6/30/09 | -0.37 6/30/09 |
-0.038
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 176,202.00 | 1.02 M |
| Gross Profit | 22,716.00 | 803,492.00 |
| Operating Income | -9.44 M | -37.15 M |
| Net Income | -9.41 M | -35.58 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts